Antibody Discovery Market Report and Forecast 2025-2034
Description
The global antibody discovery market was valued at USD 1.76 Billion in 2024, driven by the rising incidence of chronic and infectious illnesses across the globe. The market is anticipated to grow at a CAGR of 10.10% during the forecast period of 2025-2034, with the values likely to reach USD 4.61 Billion by 2034.
Antibody Discovery Market Overview
The process of antibody discovery involves identifying and developing highly specific antibodies for a specific antigen. By using specific techniques and carefully planned tests, antibodies such as IgG can selectively attach to their desired targets. Precision is essential in medical and research settings to ensure that antibodies can successfully bind to their intended targets.
Antibody Discovery Market Growth Drivers
Rising Incidence of Chronic and Infectious Illnesses is Likely to Drive Market Growth
The market growth is being driven by the increase in chronic diseases such as diabetes, cancer, and autoimmune diseases. Around 129 million Americans are affected by significant chronic illnesses like heart disease, cancer, and hypertension. Antibody therapies are successful in treating these illnesses by attaching to molecules that cause the disease with few side effects, resulting in a higher need for antibody discovery services.
Antibody Discovery Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Progress in the Field of Antibody Engineering
Utilizing nanobodies and new epitopes to research and control the behavior of the spike protein among different variants demonstrates the advancement of antibody research. A finding of the dual-function SARS-CoV-2 antibody, which can either boost or block viral entry depending on the strain, highlights the progress in antibody design. This results in increased accuracy in therapeutic uses and boosts market expansion.
Increasing Funding in AI Biotech Startups
The increased funding garnered by companies such as Xaira and Generate highlights the rising confidence in AI-powered methods for biologic design as a prevailing trend in the antibody drug discovery sector.
Rising Acquisitions and Mergers
Numerous firms are engaging in mergers and acquisitions to broaden their service offerings within the antibody discovery market. Twist Bioscience launched its antibody discovery services through its subsidiary Twist Biopharma Solutions in March 2023.
Monoclonal Antibodies as Therapeutics
The utilization of human monoclonal antibodies like MBP091, sourced from someone who survived the Marburg virus, exemplifies the increasing popularity of monoclonal antibody treatments for viral infections, cancer, and autoimmune disorders. This shows a strong demand for antibody-focused therapies.
Antibody Discovery Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Antibody Type:
Segmentation Based on Application to Witness Substantial Growth
The market is divided into monoclonal antibodies, polyclonal antibodies, and others, based on antibody type. Monoclonal antibodies are predicted to lead the global antibody market share because of their accuracy, specificity, and wide range of uses in treating different illnesses. Novel monoclonal antibodies, including bispecific antibodies and ADCs, have further enhanced their therapeutic potential.
Antibody Discovery Market Analysis by Region
The market is segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market share which can be attributed to the high incidence of chronic diseases, rising demand for personalized medicine, and substantial investment in research and development (R&D) for new antibody therapies in the region.
Leading Players in the Antibody Discovery Market
The key features of the market report comprise patent analysis, clinical trial analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Biocytogen Pharmaceuticals is a global biotech company. In December 2023, they revealed a collaboration with Ona Therapeutics, a Spanish biotech company specializing in creating groundbreaking antibody therapeutics for advanced cancer.
Evotec SE
Evotec SE is a leading pharmaceutical company that leverages advanced science, technology, and collaborations to speed up the development of treatments. The company launched the J.CHO™ High Expression System in April 2024 to enhance antibody production, increasing efficiency and quality.
Sartorius AG
Sartorius AG is an international provider of pharmaceutical and laboratory equipment, focusing on Bioprocess Solutions and Lab Products & Services. They are at the forefront of antibody discovery, making use of the iQue® HTS Cytometry Platform.
Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is a pharmaceutical company based in the United States that offers preclinical and clinical laboratory services as well as gene therapy and cell therapy services. They stand out in the global antibody discovery industry, providing customized services to meet client's needs.
Other key players in the market include Creative Biolabs, Bruker Cellular Analysis Inc., BioDuro-Sundia, Aragen Life Sciences Ltd, Abzena, and AbTherx, Inc.
Key Questions Answered in the Antibody Discovery Market
Antibody Discovery Market Overview
The process of antibody discovery involves identifying and developing highly specific antibodies for a specific antigen. By using specific techniques and carefully planned tests, antibodies such as IgG can selectively attach to their desired targets. Precision is essential in medical and research settings to ensure that antibodies can successfully bind to their intended targets.
Antibody Discovery Market Growth Drivers
Rising Incidence of Chronic and Infectious Illnesses is Likely to Drive Market Growth
The market growth is being driven by the increase in chronic diseases such as diabetes, cancer, and autoimmune diseases. Around 129 million Americans are affected by significant chronic illnesses like heart disease, cancer, and hypertension. Antibody therapies are successful in treating these illnesses by attaching to molecules that cause the disease with few side effects, resulting in a higher need for antibody discovery services.
Antibody Discovery Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Progress in the Field of Antibody Engineering
Utilizing nanobodies and new epitopes to research and control the behavior of the spike protein among different variants demonstrates the advancement of antibody research. A finding of the dual-function SARS-CoV-2 antibody, which can either boost or block viral entry depending on the strain, highlights the progress in antibody design. This results in increased accuracy in therapeutic uses and boosts market expansion.
Increasing Funding in AI Biotech Startups
The increased funding garnered by companies such as Xaira and Generate highlights the rising confidence in AI-powered methods for biologic design as a prevailing trend in the antibody drug discovery sector.
Rising Acquisitions and Mergers
Numerous firms are engaging in mergers and acquisitions to broaden their service offerings within the antibody discovery market. Twist Bioscience launched its antibody discovery services through its subsidiary Twist Biopharma Solutions in March 2023.
Monoclonal Antibodies as Therapeutics
The utilization of human monoclonal antibodies like MBP091, sourced from someone who survived the Marburg virus, exemplifies the increasing popularity of monoclonal antibody treatments for viral infections, cancer, and autoimmune disorders. This shows a strong demand for antibody-focused therapies.
Antibody Discovery Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Antibody Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
- Others
- Phage Display
- Hybridoma
- Others
- Pharmaceutical and Biopharmaceutical Companies
- Research Laboratories
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Segmentation Based on Application to Witness Substantial Growth
The market is divided into monoclonal antibodies, polyclonal antibodies, and others, based on antibody type. Monoclonal antibodies are predicted to lead the global antibody market share because of their accuracy, specificity, and wide range of uses in treating different illnesses. Novel monoclonal antibodies, including bispecific antibodies and ADCs, have further enhanced their therapeutic potential.
Antibody Discovery Market Analysis by Region
The market is segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market share which can be attributed to the high incidence of chronic diseases, rising demand for personalized medicine, and substantial investment in research and development (R&D) for new antibody therapies in the region.
Leading Players in the Antibody Discovery Market
The key features of the market report comprise patent analysis, clinical trial analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Biocytogen Pharmaceuticals is a global biotech company. In December 2023, they revealed a collaboration with Ona Therapeutics, a Spanish biotech company specializing in creating groundbreaking antibody therapeutics for advanced cancer.
Evotec SE
Evotec SE is a leading pharmaceutical company that leverages advanced science, technology, and collaborations to speed up the development of treatments. The company launched the J.CHO™ High Expression System in April 2024 to enhance antibody production, increasing efficiency and quality.
Sartorius AG
Sartorius AG is an international provider of pharmaceutical and laboratory equipment, focusing on Bioprocess Solutions and Lab Products & Services. They are at the forefront of antibody discovery, making use of the iQue® HTS Cytometry Platform.
Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is a pharmaceutical company based in the United States that offers preclinical and clinical laboratory services as well as gene therapy and cell therapy services. They stand out in the global antibody discovery industry, providing customized services to meet client's needs.
Other key players in the market include Creative Biolabs, Bruker Cellular Analysis Inc., BioDuro-Sundia, Aragen Life Sciences Ltd, Abzena, and AbTherx, Inc.
Key Questions Answered in the Antibody Discovery Market
- What was the antibody discovery market value in 2024?
- What is the antibody discovery market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on antibody type?
- What is the market segmentation based on service?
- What is the market breakup based on the end user?
- What are the major factors aiding the antibody discovery market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the antibody discovery market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Antibody Discovery Market Overview
- 3.1 Global Antibody Discovery Market Historical Value 2018-2024
- 3.2 Global Antibody Discovery Market Forecast Value 2025-2034
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Antibody Discovery Market Landscape*
- 5.1 Global Antibody Discovery Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Antibody Discovery Market: Product Landscape
- 5.2.1 Analysis by Antibody Type
- 5.2.2 Analysis by Service
- 6 Global Antibody Discovery Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Antibody Discovery Market Segmentation 218-2034
- 7.1 Global Antibody Discovery Market 2018-2034 by Antibody Type
- 7.1.1 Market Overview
- 7.1.2 Monoclonal Antibodies
- 7.1.3 Polyclonal Antibodies
- 7.1.4 Others
- 7.2 Global Antibody Discovery Market 2018-2034 by Service
- 7.2.1 Market Overview
- 7.2.2 Phage Display
- 7.2.3 Hybridoma
- 7.2.4 Others
- 7.3 Global Antibody Discovery Market 2018-2034 by End User
- 7.3.1 Market Overview
- 7.3.2 Pharmaceutical and Biopharmaceutical Companies
- 7.3.3 Research Laboratories
- 7.3.4 Others
- 7.4 Global Antibody Discovery Market 2018-2034 by Region
- 7.4.1 Market Overview
- 7.4.2 North America
- 7.4.3 Europe
- 7.4.4 Asia Pacific
- 7.4.5 Latin America
- 7.4.6 Middle East and Africa
- 8 North America Antibody Discovery Market 218-2034
- 8.1 North America Antibody Discovery Market 2018-2034 by Antibody Type
- 8.1.1 Market Overview
- 8.1.2 Monoclonal Antibodies
- 8.1.3 Polyclonal Antibodies
- 8.1.4 Others
- 8.2 North America Antibody Discovery Market 2018-2034 by Service
- 8.2.1 Market Overview
- 8.2.2 Phage Display
- 8.2.3 Hybridoma
- 8.2.4 Others
- 8.3 North America Antibody Discovery Market 2018-2034 by End User
- 8.3.1 Market Overview
- 8.3.2 Pharmaceutical and Biopharmaceutical Companies
- 8.3.3 Research Laboratories
- 8.3.4 Others
- 8.4 North America Antibody Discovery Market 2018-2034 by Country
- 8.4.1 United States of America
- 8.4.2 Canada
- 9 Europe Antibody Discovery Market 218-2034
- 9.1 Europe Antibody Discovery Market 2018-2034 by Antibody Type
- 9.1.1 Market Overview
- 9.1.2 Monoclonal Antibodies
- 9.1.3 Polyclonal Antibodies
- 9.1.4 Others
- 9.2 Europe Antibody Discovery Market 2018-2034 by Service
- 9.2.1 Market Overview
- 9.2.2 Phage Display
- 9.2.3 Hybridoma
- 9.2.4 Others
- 9.3 Europe Antibody Discovery Market 2018-2034 by End User
- 9.3.1 Market Overview
- 9.3.2 Pharmaceutical and Biopharmaceutical Companies
- 9.3.3 Research Laboratories
- 9.3.4 Others
- 9.4 Europe Antibody Discovery Market 2018-2034 by Country
- 9.4.1 United Kingdom
- 9.4.2 Germany
- 9.4.3 France
- 9.4.4 Italy
- 9.4.5 Others
- 10 Asia Pacific Antibody Discovery Market 218-2034
- 10.1 Asia Pacific Antibody Discovery Market 2018-2034 by Antibody Type
- 10.1.1 Market Overview
- 10.1.2 Monoclonal Antibodies
- 10.1.3 Polyclonal Antibodies
- 10.1.4 Others
- 10.2 Asia Pacific Antibody Discovery Market 2018-2034 by Service
- 10.2.1 Market Overview
- 10.2.2 Phage Display
- 10.2.3 Hybridoma
- 10.2.4 Others
- 10.3 Asia Pacific Antibody Discovery Market 2018-2034 by End User
- 10.3.1 Market Overview
- 10.3.2 Pharmaceutical and Biopharmaceutical Companies
- 10.3.3 Research Laboratories
- 10.3.4 Others
- 10.4 Asia Pacific Antibody Discovery Market 2018-2034 by Country
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 ASEAN
- 10.4.5 Australia
- 10.4.6 Others
- 11 Latin America Antibody Discovery Market 218-2034
- 11.1 Latin America Antibody Discovery Market 2018-2034 by Antibody Type
- 11.1.1 Market Overview
- 11.1.2 Monoclonal Antibodies
- 11.1.3 Polyclonal Antibodies
- 11.1.4 Others
- 11.2 Latin America Antibody Discovery Market 2018-2034 by Service
- 11.2.1 Market Overview
- 11.2.2 Phage Display
- 11.2.3 Hybridoma
- 11.2.4 Others
- 11.3 Latin America Antibody Discovery Market 2018-2034 by End User
- 11.3.1 Market Overview
- 11.3.2 Pharmaceutical and Biopharmaceutical Companies
- 11.3.3 Research Laboratories
- 11.3.4 Others
- 11.4 Latin America Antibody Discovery Market 2018-2034 by Country
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Mexico
- 11.4.4 Others
- 12 Middle East and Africa Antibody Discovery Market 218-2034
- 12.1 Middle East and Africa Antibody Discovery Market 2018-2034 by Antibody Type
- 12.1.1 Market Overview
- 12.1.2 Monoclonal Antibodies
- 12.1.3 Polyclonal Antibodies
- 12.1.4 Others
- 12.2 Middle East and Africa Antibody Discovery Market 2018-2034 by Service
- 12.2.1 Market Overview
- 12.2.2 Phage Display
- 12.2.3 Hybridoma
- 12.2.4 Others
- 12.3 Middle East and Africa Antibody Discovery Market 2018-2034 by End User
- 12.3.1 Market Overview
- 12.3.2 Pharmaceutical and Biopharmaceutical Companies
- 12.3.3 Research Laboratories
- 12.3.4 Others
- 12.4 Middle East and Africa Antibody Discovery Market 2018-2034 by Country
- 12.4.1 Saudi Arabia
- 12.4.2 United Arab Emirates
- 12.4.3 Nigeria
- 12.4.4 South Africa
- 12.4.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Drug Class of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Drug Class of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Company News and Development
- 17.2.5 Certifications
- 17.3 Evotec SE
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Company News and Development
- 17.3.5 Certifications
- 17.4 Sartorius AG
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Company News and Development
- 17.4.5 Certifications
- 17.5 Charles River Laboratories International, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Company News and Development
- 17.5.5 Certifications
- 17.6 Creative Biolabs.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Company News and Development
- 17.6.5 Certifications
- 17.7 Bruker Cellular Analysis Inc
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Company News and Development
- 17.7.5 Certifications
- 17.8 BioDuro-Sundia
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Company News and Development
- 17.8.5 Certifications
- 17.9 Aragen Life Sciences Ltd
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Company News and Development
- 17.9.5 Certifications
- 17.10 Abzena
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Company News and Development
- 17.10.5 Certifications
- 17.11 AbTherx, Inc
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Company News and Development
- 17.11.5 Certifications
- 18 Global Antibody Discovery Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
